个人简介：
赵晓燕，女，药理学博士，副教授，硕士生导师，毕业于哈尔滨医科大学药理学专业，师从杨宝峰院士，中国药理学会第十届心血管药理专业委员会委员。
主要研究领域及教学内容：
主要研究领域为心血管药理学，抗肿瘤药物和抗糖尿病药物的研究。承担本科生的《药理学》、《药物毒理学》、《临床医学概论》和硕士研究生的《药学进展》等课程的教学工作。
主持/参与课题：
先后主持国家自然基金1项，中央高校科研基本业务费2项，西南大学博士基金1项，横向项目1项等。发表SCI收录论文10余篇。
代表性教学科研成果：
在《BrJPharmacol》和《PlosOne》等刊物上发表发表SCI收录论文十余篇。
1.ZhaoXY,LiGY,LiuY,ChaiLM,ChenJX,ZhangY,LuYJ,YangBF.Resveratrolprotectsagainstarsenictrioxide-inducedcardiotoxicityinvitroandinvivo.BrJPharmacol.2008;154(1):105-13.
2.ZhaoXY,FengTM,ChenH,ShanHL,ZhangY,LuYJ,YangBF.Arsenictrioxide-inducedapoptosisinH9c2cardiomyocytes:implicationsincardiotoxicity.BasicClinPharmacolToxicol.2008;102(5):419-25.
3.ZhaoXY,QiaoGF,LiBX,ChaiLM,LiZ,LuYJ,YangBF.HypoglycemicandhypolipidemiceffectsofemodinanditsInfluenceonL-typeCalciumChannelsindyslipidemic-diabeticrats.ClinicalandExperimentalPharmacologyandPhysiology.2009;36(1):29-34.
4.ZhaoXY,ZhangJ,TongNN,LiaoXG,WangEB,LiZB,LuoYH,ZuoH.Berberineattenuatesdoxorubicin-inducedcardiotoxicityinmice；TheJournalofInternationalMedicalResearch.2011;39(5):1720-1727.
5.ZhaoXY,ZhangJ,TongNN,ChenYR,LuoYH.Protectiveeffectsofberberineondoxorubicin-inducedhepatotoxicityinmice;BiologicalandPharmaceuticalBulletin.2012;35(5):796-800.
6.ZhaoXY,TongNN.Protectiveeffectsofberberineondoxorubicin-inducednephrotoxicityinmice.JournalofTranslationalMedicine2012;10(Suppl2):A66.
7.ZhaoXY,YangS,ChenYR,LiPC,DouMM,ZhangJ.Resveratrolandarsenictrioxideactsynergisticallytokilltumorcellsinvitroandinvivo.PLoSOne.2014Jun5;9(6):e98925.
8.ChenY,LiP,YangS,TongN,ZhangJ,ZhaoX.Tetrandrineenhancestheanticancereffectsofarsenictrioxideinvitro.IntJClinPharmacolTher.2014May;52(5):416-24.(通讯作者)
9.LiPC,YangS,DouMM,ChenYR,ZhangJ,ZhaoXY.Synergiceffectsofartemisininandresveratrolincancercells.JournalofCancerResearchandClinicalOncology.2014.DOI:10.1007/s00432-014-1771-7.(通讯作者)
10.TongNN,ZhangJ,ChenYR,LiZB,LuoYH,ZuoH,ZhaoXY.Berberinesensitizesmutliplehumancancercellstotheanticancereffectsofdoxorubicininvitro.OncologyLetters;2012;3(6):1263-1267.(通讯作者)
11.ZhangJ,TongNN,ChenYR,LiPC,YangS,ZhaoXY.Resveratrolprotectsagainstvinorelbine-inducedvascularendothelialcellinjury.ToxicolMechMethods.2013Nov;23(9):665-71.(通讯作者)
12.ChenYR,LiPC,YangS,TongNN，ZhangJ，ZhaoXY.Tetrandrineenhancestheanticancereffectsofarsenictrioxideinvitro.InternationalJournalofClinicalPharmacologyandTherapeutics.2014May;52(5):416-24.（通讯作者）
13.ChenM,LiZB,ZhaoXY,ZuoH,HeX,LiZ,LiuX,ChenL.EffectofdiallyltrisulfidederivativesontheinductionofapoptosisinhumanprostatecancerPC-3cells.MolCellBiochem.2012Apr;363(1-2):75-84.
14.GeZK,LuoYH,ZhaoXY,ZhangYJ,ZhangH,TianCC.SimultaneousdeterminationofibuprofenanddiphenhydramineHClinorallydisintegratingtabletsanditsdissolutionbyreversed-phasehighperformanceliquidchromatography(RP-HPLC).AfricanJournalofPharmacyandPharmacology.2011,5(18):2100-2105.
15.ZhangH,LuoYH,ZhaoXY,ChenQ,LuoM,LuoLY,TianCC,GeZK,ZhangYJ.Preparationofcarteololhydrochloridematrixsustained-releasepelletsandevaluationinvitro/invivo.AfricanJournalofPharmacyandPharmacology.2012,6(11):829-833.
16.TianCC,LuoYH,ZhaoXY,ChenQ,LuoM,LuoLY.ComponentsAnalysisofVolatileMatterinSimethiconebyGasChromatography-MassSpectrometry.ComponentsAtrometry.AfricanJournalofPharmacyandPharmacology.2012,8(12):711-715.
LuoYH,GeZK,ZhaoXY,ChenQ,NadiaBOURKAIB,LuoM,LuoLY,WuL,HuBX.PreparationandQualityEvaluationofIbuprofenandDiphenhydramineHydrochlorideOrallyDisintegratingTablets.LatinAmericanJournalofPharmacy.2012,31(6):852-7.

邮箱：zhaoxiaoyan67@163.com